Maternal Folate Levels Linked to Congenital Heart Defects

The Role of Active Folate for Human Health

Folate is essential for DNA synthesis, homocysteine regulation, and neurotransmitter production, processes critical for energy, brain function, and overall vitality.  

However, up to 40% of the population carries genetic variants (e.g., MTHFR C677T) that impair the conversion of synthetic folic acid into its active form, leading to accumulation of unmetabolized folic acid (UMFA) and potential health risks.

In contrast, 5-MTHF, like Quatrefolic^®, bypasses this metabolic bottleneck, ensuring optimal bioavailability and reducing the risk of B12 deficiency, a major concern with high-dose folic acid. 

Study suggests optimal maternal folate levels may be key to heart development

The findings, published in JAMA Network Open, come from a case-control study conducted in China involving 129 pregnancies affected by congenital heart defects and 516 control pregnancies. Researchers measured maternal serum folate, vitamin B12, and homocysteine concentrations at approximately 16 weeks’ gestation and examined their associations with the risk of CHDs. 

The analysis identified a U-shaped relationship between maternal folate levels and congenital heart defects. Women with the lowest folate concentrations had approximately a threefold higher risk of having a child with a congenital heart defect compared with women whose folate levels were in the middle range. 

Women with the highest folate concentrations also showed a significantly increased risk, although the association was more modest.

Using the World Health Organization’s folate categories, the researchers found that the risk remained highest at both ends of the folate spectrum, suggesting that maintaining folate within an optimal range may be important for healthy fetal cardiac development. 

Quatrefolic^®, the bioactive folate, can ensure that women get the right amount of folate during pregnancy.

The study also found that the association between non-optimal folate levels and congenital heart defects appeared to be stronger among women with vitamin B12 deficiency or elevated homocysteine concentrations. These findings support the importance of one-carbon metabolism, in which folate, vitamin B12, and homocysteine work together to support normal embryonic development. 

Periconceptional folate supplementation remains a cornerstone of international recommendations for preventing birth defects. Instead, the results suggest that avoiding both folate deficiency and excessive folate exposure, while ensuring adequate vitamin B12 status, may be important for optimizing pregnancy outcomes.

Unlike high-dose folic acid, Quatrefolic® may help reduce the risk of masking vitamin B12 deficiency.